Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular risk. [PDF]
Emanuelsson F, Nordestgaard BG, Benn M.
europepmc +1 more source
More than a sidekick: GIP signalling and cardiovascular outcomes. [PDF]
Kurt B, Kahles F.
europepmc +1 more source
Interaction between fatty pancreas disease and genetically predicted glucose-dependent insulinotropic polypeptide on incident type 2 diabetes: evidence from the UK Biobank. [PDF]
Wang X +8 more
europepmc +1 more source
GLP-1 Agonists in Adolescent Obesity: A Narrative Review of Single, Dual, and Triple Agonists. [PDF]
Abid M, Sheikh KS, Ahmad MS, Jiang H.
europepmc +1 more source
GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice. [PDF]
Liskiewicz D +52 more
europepmc +1 more source
Anti-GIP antibodies and future diabetes related risk: an eight-year prospective cohort study. [PDF]
Hashimoto T +12 more
europepmc +1 more source
Restoring Satiety After GLP-1/GIP Pharmacotherapy: Metabolic Stability, Diet Quality, and the Gut Microbiota. [PDF]
Lasik L, Ukleja-Sokołowska N.
europepmc +1 more source
Prevalence and Risk Factors of Gastrointestinal Parasitic Infections in Buffaloes Across Commercial and Subsistence Farming Systems in Butwal, Nepal. [PDF]
Neupane A +4 more
europepmc +1 more source
Changes in incretin hormone concentrations after pancreaticoduodenectomy: a systematic review and exploratory meta-analysis. [PDF]
Grząsiak-Kraj O +4 more
europepmc +1 more source
Chronic Glycaemic Control Modulates the Relationship Between GIP and Glucagon Secretion Following Oral and Enteral Nutrients in Type 2 Diabetes. [PDF]
Wang Z +7 more
europepmc +1 more source

